Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Hemodialysis International. International Symposium on Home Hemodialysis|November 3, 2010
Utility of citrate dialysate in management of acute kidney injury in childrenCoral Hanevold, Sharon Lu, Karyn YonekawaBritish Journal of Clinical Pharmacology|February 24, 2023
Dostarlimab, an anti-programmed death-1 monoclonal antibody, does not cause QT prolongation in patients with solid tumours: A concentration-QT analysisMita Kuchimanchi, Christine Dabrowski, Sharon Lu, et al.CPT: Pharmacometrics & Systems Pharmacology|November 1, 2022
Comparative analysis of PD-1 target engagement of dostarlimab and pembrolizumab in advanced solid tumors using ex vivo IL-2 stimulation dataDaren Austin, Murad Melhem, Yash Gandhi, et al.American Journal of Preventive Medicine|August 4, 2007
Population-based linkage of AIDS and cancer registries: importance of linkage algorithmDennis Deapen, Myles Cockburn, Rich Pinder, et al.British Journal of Clinical Pharmacology|March 31, 2022
Population pharmacokinetics and exposure-response of anti-programmed cell death protein-1 monoclonal antibody dostarlimab in advanced solid tumoursMurad Melhem, Eva Hanze, Sharon Lu, et al.Journal of Clinical Pharmacology|January 13, 2018
Pharmacokinetics of Rolapitant in Patients With Mild to Moderate Hepatic ImpairmentJing Wang, Xiaodong Wang, Zhi-Yi Zhang, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 2018
Effects of rolapitant administered orally on the pharmacokinetics of dextromethorphan (CYP2D6), tolbutamide (CYP2C9), omeprazole (CYP2C19), efavirenz (CYP2B6), and repaglinide (CYP2C8) in healthy subjectsJing Wang, Zhi-Yi Zhang, Sharon Lu, et al.Journal of Clinical Pharmacology|April 26, 2018
Effects of Rolapitant Administered Intravenously on the Pharmacokinetics of a Modified Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan) in Healthy SubjectsXiaodong Wang, Zhi-Yi Zhang, Sujata Arora, et al.Clinical Pharmacology in Drug Development|June 16, 2018
Pharmacokinetics, Safety, and Tolerability of Rolapitant Administered Intravenously Following Single Ascending and Multiple Ascending Doses in Healthy SubjectsXiaodong Wang, Zhi-Yi Zhang, Jing Wang, et al.Journal of Clinical Pharmacology|November 14, 2018
Pharmacokinetic Interactions of Rolapitant With Cytochrome P450 3A Substrates in Healthy SubjectsXiaodong Wang, Jing Wang, Sujata Arora, et al.Pageof 3